Assaying for circulating osteopontin in practice: a technical note

Constantinescu D., Vornicu M., Grigoriu C., Cozmei C., Grigoriu B. D.

Source: Eur Respir J 2010; 35: 1187-1188
Journal Issue: May

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Constantinescu D., Vornicu M., Grigoriu C., Cozmei C., Grigoriu B. D.. Assaying for circulating osteopontin in practice: a technical note. Eur Respir J 2010; 35: 1187-1188

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Is there any clinical application for determining the serum cytokines profile in sarcoid patients?
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008

Guidance production before evidence generation for critical issues: the example of COVID-19
Source: Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020
Year: 2020



High levels of serum cholesterol – protective and predictive factor for activation of tuberculosis; practical considerations
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009

Reference article: NIV in the acute setting: technical aspects, initiation, monitoring and choice of interface
Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course
Year: 2012

LATE-BREAKING ABSTRACT: Expression and clinical diagnostic efficacy of serum PCT and macrophage migration inhibitory factor in patients with sepsis
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013

YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre
Source: International Congress 2017 – Rare diseases
Year: 2017


Elevated chitotriosidase levels in patient with pumonary tuberculosis: correlation with radiologic extent and degree of smaer positiviy
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Circulating fibrocytes and collagen turnover products in UIP: marker of disease activity and prognostic tool?
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007

Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Secretion clearance and management techniques: how do I make it work?
Source: ERS Skills Course 2016
Year: 2016

Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?
Source: ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019
Year: 2020



Exercise: define research priorities at programmatic level
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Low tri-iodothyronine state: a relevant factor in determining outcome in thoracic surgery patients? Evidence from a clinical study
Source: Eur Respir J 2004; 24: Suppl. 48, 41s
Year: 2004

Lung function testing in the COVID era: safety concerns you should consider
Source: COVID-19 Videos
Year: 2020

Late Breaking Abstract - Matrix metalloproteinases in serum and sputum reflect distinct processes of relevance to asthma
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019